DR. ARI D. FISHMAN M.D. NPI 1407963036

NPI Information

  • NPI: 1407963036
  • Provider Name: DR. ARI D. FISHMAN, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 7525 GREENWAY CENTER DR
    SUITE 205
    GREENBELT, MD
    ZIP 20770
  • Phone: (301) 982-9800

Map and Directions

Get Directions

NPI Details

DR. Ari D. Fishman, M.D. is a hematology and oncology internal medicine in Greenbelt, MD with 31 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Ari D. Fishman, M.D. NPI is 1407963036. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
Graduation Year:1995

The provider's business location address is:

7525 GREENWAY CENTER DR
SUITE 205
GREENBELT, MD
ZIP 20770-509
Phone: (301) 982-9800
Fax: (301) 982-2420

The NPI 1407963036 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Measurement of substance using immunoassay technique (HCPCS:83520)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Unclassified drugs (HCPCS:J3490)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
  • Haptoglobin (serum protein) level (HCPCS:83010)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
  • Folic acid level, serum (HCPCS:82746)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
  • Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
  • Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
  • Stool analysis for blood to screen for colon tumors (HCPCS:82270)

The enumeration date for this NPI number is 8/23/2006 and was last updated on 7/25/2014.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & OncologyD0057475MARYLANDYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1348232YEH2MEDICARE PINMARYLAND

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.